Renaissance Technologies’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Renaissance Technologies’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-626,789	Closed	-$74M	–	3917
2020 Q4	$74M	Sell	626,789 -216,238	-26%	-$25.1M	0.08%	252
2020 Q3	$93.7M	Buy	843,027 +219,886	+35%	+$23.6M	0.09%	227
2020 Q2	$63.7M	Buy	623,141 +371,745	+148%	+$39.8M	0.06%	363
2020 Q1	$27.1M	Buy	251,396 +205,696	+450%	+$23.6M	0.03%	628
2019 Q4	$5.32M	Buy	45,700 +30,700	+205%	+$3.56M	﹤0.01%	1813
2019 Q3	$1.72M	Buy	15,000 +5,900	+65%	+$587K	﹤0.01%	2356
2019 Q2	$867K	Sell	9,100 -21,900	-71%	-$2.06M	﹤0.01%	2748
2019 Q1	$2.83M	Buy	31,000 +22,900	+283%	+$1.87M	﹤0.01%	2134
2018 Q4	$615K	Sell	8,100 -46,700	-85%	-$3.44M	﹤0.01%	2787
2018 Q3	$4.38M	Sell	54,800 -68,800	-56%	-$6.41M	﹤0.01%	1891
2018 Q2	$12.3M	Buy	123,600 +11,900	+11%	+$1.03M	0.01%	1230
2018 Q1	$9.05M	Buy	111,700 +9,400	+9%	+$760K	0.01%	1433
2017 Q4	$8.06M	Sell	102,300 -99,800	-49%	-$8.3M	0.01%	1510
2017 Q3	$18.6M	Buy	202,100 +120,000	+146%	+$11.5M	0.02%	944
2017 Q2	$9.29M	Sell	82,100 -166,900	-67%	-$18.7M	0.01%	1320
2017 Q1	$24.9M	Buy	249,000 +102,504	+70%	+$11M	0.03%	676
2016 Q4	$15.8M	Sell	146,496 -115,604	-44%	-$13.5M	0.02%	935
2016 Q3	$32.6M	Buy	262,100 +33,100	+14%	+$3.91M	0.06%	444
2016 Q2	$24.3M	Sell	229,000 -140,700	-38%	-$16.3M	0.05%	572
2016 Q1	$42.3M	Sell	369,700 -7,400	-2%	-$868K	0.08%	295
2015 Q4	$53.7M	Sell	377,100 -12,000	-3%	-$1.39M	0.12%	196
2015 Q3	$34.9M	Buy	389,100 +69,600	+22%	+$7.35M	0.08%	290
2015 Q2	$36.8M	Sell	319,500 -29,222	-8%	-$3.07M	0.08%	274
2015 Q1	$33.3M	Buy	348,722 +72,622	+26%	+$5.43M	0.07%	365
2014 Q4	$18.6M	Buy	276,100 +53,500	+24%	+$3.32M	0.04%	549
2014 Q3	$12M	Buy	222,600 +22,500	+11%	+$1.11M	0.03%	659
2014 Q2	$8.9M	Buy	200,100 +69,725	+53%	+$2.85M	0.02%	909
2014 Q1	$4.53M	Buy	130,375 +11,975	+10%	+$381K	0.01%	1316
2013 Q4	$3.42M	Buy	118,400 +23,900	+25%	+$693K	0.01%	1430
2013 Q3	$2.76M	Buy	94,500 +9,700	+11%	+$242K	0.01%	1507
2013 Q2	$1.97M	Buy	+84,800	New	+$2.14M	0.01%	1590

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Renaissance Technologies's CBPO Position: Q1 2021 in Review

Renaissance Technologies sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 626,789 shares — an estimated $74M sold.

Renaissance Technologies first reported a position in CBPO in Q2 2013 and held it in 31 quarters. The position peaked at $93.7M in Q3 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

Renaissance Technologies reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
Renaissance Technologies sold 626,789 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $74M.
Renaissance Technologies first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 31 quarters.
Renaissance Technologies's China Biologic Products Holdings, Inc. position peaked at $93.7M in Q3 2020.
86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.